Variations of plasma enzymes in the pony and the dog after carbon tetrachloride administration.

The research sought to understand how several plasma enzymes, which are often indicative of liver disease, react after being subjected to a nonlethal dose of carbon tetrachloride (CCl4) in adult female dogs and ponies. The results showed distinct responses in both animals, suggesting that they should be considered as separate entities when conducting lab tests for diagnosing liver diseases.

Experiment Overview

• The experiment involved the administration of a nonlethal dose of CCl4 (0.5 ml/kg of body weight) to adult female dogs and pony mares. This chemical compound was chosen as it is known to cause liver damage.
• Several plasma enzymes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), arginase, gamma-glutamyltransferase (GGT), and iditol dehydrogenase (ID), were monitored in these animals both before and after the CCl4 administration. These enzymes are known to indicate the presence of liver disease.
• Levels of total plasma bilirubin – another indication of liver disease – were also determined in both dogs and ponies after the administration of CCl4.

Results on Dogs

• In dogs, GGT levels did not show a significant increase after CCl4 administration, a significant finding given that elevated GGT levels are often associated with liver disease.
• However, the levels of ALP in dogs recorded an increase starting from the first day up to the sixth day after CCl4 administration. An increased level of ALP is also usually indicative of liver disease.
• It is important to note that increases in both GGT and ALP may reflect changes in the liver following the introduction of the CCl4 toxin.

Results on Ponies

• The research found that in ponies, GGT levels significantly increased during the whole course of the study post-administration of CCl4, showing a varying response to the toxin than observed in dogs.
• In contrast to the pattern observed in dogs, the ALP levels in ponies showed only small and temporary increases, though these were still significant.
• This suggests differing reactions to liver damage in ponies due to the administration of CCl4, which should be accounted for in clinical evaluations.

Shared Results and Conclusion

• Total bilirubin in both dogs and ponies increased significantly in the early days right after the CCl4 dose but eventually returned to or decreased below base-line values.
• The responses of ID, AST, and ALP were found to be unremarkable when directly comparing the test results of the pony and the dog.
• Despite the alterations in enzyme levels, there was no evidence of icterus – a yellowing condition associated with liver disease – in any of the animals at any time during the study.
• This suggests that the dog and pony have distinct responses to liver damage, indicating that they should be treated as unique clinical entities. Therefore, it is recommended to use appropriate tests depending on the animal species while diagnosing hepatic diseases.